Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

…, A Gopher, S Almog, BR Martin, DR Compton… - Biochemical …, 1995 - Elsevier
In this study, we report the isolation from canine intestines of 2-arachidonyl glycerol (2-Ara-Gl).
Its structure was determined by mass spectrometry and by direct comparison with a …

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

VM Showalter, DR Compton, BR Martin… - Journal of Pharmacology …, 1996 - ASPET
Two cannabinoid receptors have been identified to date; one is located predominantly in
the central nervous system (CB1), whereas the other is located exclusively in the periphery (…

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

…, K Varga, KD Lake, DR Compton… - Proceedings of the …, 1999 - National Acad Sciences
Cannabinoids, including the endogenous ligand arachidonyl ethanolamide (anandamide),
elicit not only neurobehavioral but also cardiovascular effects. Two cannabinoid receptors, …

[PDF][PDF] Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

DR Compton, KC Rice, BR De Costa… - … of Pharmacology and …, 1993 - researchgate.net
Although a receptor exists for cannabinoid drugs, it is uncertain which pharmacological
actions this receptor mediates. This structure-activity relationship investigation was initiated to …

Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs

BR Martin, DR Compton, BF Thomas… - Pharmacology …, 1991 - Elsevier
Numerous cannabinoids have been synthesized that are extremely potent in all of the
behavioral assays conducted in our laboratory. An important feature in increasing potency has …

[PDF][PDF] The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice

PB Smith, DR Compton, SP Welch… - … of Pharmacology and …, 1994 - druglibrary.org
The arachidonic acid derivative anandamide (arachidonylethan-olamide) has been isolated
from porcine brain and has been shown to bind competitively to the cannabinoid receptor. …

Design, synthesis and pharmacology of cannabimimetic indoles

JW Huffman, D Dai, BR Martin, DR Compton - Bioorganic & Medicinal …, 1994 - Elsevier
… to 19% yield All of the indoles were evaluated in virro by measuring their ability to displace
[3Hl CP-55,940 (2) from its binding site in a membrane preparation as described by Compton

Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

PJ Little, DR Compton, MR Johnson, LS Melvin… - … of Pharmacology and …, 1988 - ASPET
The pharmacological effects of three stereoisomeric pairs of structurally novel cannabinoids
were tested after iv administration in mice for depression of spontaneous activity and the …

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent …

DR Compton, MD Aceto, J Lowe, BR Martin - Journal of Pharmacology and …, 1996 - ASPET
SR141716A has been described as a cannabinoid receptor antagonist. This study was
conducted to determine whether SR141716A was capable of antagonizing the pharmacological …

Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol.

DR Compton, LH Gold, SJ Ward, RL Balster… - … of Pharmacology and …, 1992 - ASPET
Six novel aminoalkylindole analogs, related structurally to the dual cyclooxygenase inhibitor
and nonopioid analgesic pravadoline, were evaluated in the mouse to determine whether …